Your browser doesn't support javascript.
loading
Long-term efficacy and safety of tamsulosin hydrochloride for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia: data from China / 中华医学杂志(英文版)
Chinese Medical Journal ; (24): 56-60, 2011.
Article in English | WPRIM | ID: wpr-241531
ABSTRACT
<p><b>BACKGROUND</b>Tamsulosin hydrochloride can significantly improve benign prostatic hyperplasia (BPH) symptoms after the first dose and achieve long-term efficacy in European and American populations; however, the corresponding studies from China are rarely seen. The purpose of this study was to evaluate the long-term efficacy and safety of tamsulosin hydrochloride 0.2 mg once daily in patients with lower urinary tract symptoms (LUTS) suggestive of BPH in China.</p><p><b>METHODS</b>Chinese patients with LUTS suggestive of BPH were enrolled in a 4-week placebo run-in period and subsequent 60-week open-label study. Tamsulosin hydrochloride 0.2 mg was administered daily during the period of the study. The efficacy and safety parameters were evaluated at the end of treatment period I (0 - 12 weeks) and period II (13 - 60 weeks). The BPH patients were divided into tamsulosin monotherapy group and combination therapy group which received concomitant medication of finasteride 5 mg once daily after the evaluation at the end of treatment period I.</p><p><b>RESULTS</b>A total of 113 patients were recruited to the study. Eighty-two patients received tamsulosin monotherapy and twenty-nine received combination therapy during the treatment period II. Tamsulosin hydrochloride produced a great improvement in mean maximum urinary flow rate (Q(max)) (1.7 ml/s, 3 ml/s) and a significant decrease in mean international prostate symptom score (IPSS) (4.1, 6.4) after 12-week and 60-week treatments, respectively. At the end of treatment period II, there were significant improvement in IPSS, quality of life (QOL) score, Q(max) and average flow rate (Q(ave)) for combination therapy group compared with the treatment period I (all P < 0.05). No serious adverse events (SAE) were recorded during the study.</p><p><b>CONCLUSION</b>Long-term tamsulosin hydrochloride therapy is a safe, effective and well-tolerated method for the treatment for LUTS suggestive of BPH in China.</p>
Subject(s)
Full text: Available Index: WPRIM (Western Pacific) Main subject: Placebos / Prostatic Hyperplasia / Sulfonamides / China / Therapeutic Uses / Drug Therapy / Prostatism / Adrenergic alpha-1 Receptor Antagonists Type of study: Controlled clinical trial Limits: Aged / Humans / Male Country/Region as subject: Asia Language: English Journal: Chinese Medical Journal Year: 2011 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Placebos / Prostatic Hyperplasia / Sulfonamides / China / Therapeutic Uses / Drug Therapy / Prostatism / Adrenergic alpha-1 Receptor Antagonists Type of study: Controlled clinical trial Limits: Aged / Humans / Male Country/Region as subject: Asia Language: English Journal: Chinese Medical Journal Year: 2011 Type: Article